{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:16Z","timestamp":1772166316795,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Pudong New Area Health Commission Discipline Construction Project-Clinical Plateau Discipline","award":["PWYgy2021-01"],"award-info":[{"award-number":["PWYgy2021-01"]}]},{"name":"Shanghai Pudong New Area Health Commission Discipline Construction Project -Key Subject Group","award":["PWZxq2022-14"],"award-info":[{"award-number":["PWZxq2022-14"]}]},{"name":"Pudong New Area Clinical Characteristic Discipline Project","award":["PWYts2021-11"],"award-info":[{"award-number":["PWYts2021-11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00654-2","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:24:46Z","timestamp":1744219486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Congcong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuxiong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenying","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinna","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Hobeika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert Kim","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"29","key":"654_CR1","first-page":"655","volume":"5","author":"Reported Cases and Deaths of National Notifiable Infectious Diseases \u2014 China","year":"2023","unstructured":"Reported Cases and Deaths of National Notifiable Infectious Diseases \u2014 China. Dec 2022* CCDCW. 2023;5(29):655\u20136.","journal-title":"Dec 2022* CCDCW"},{"key":"654_CR2","doi-asserted-by":"crossref","unstructured":"Reported Cases and Deaths of National Notifiable Infectious Diseases - China. November 2022. China CDC Wkly. 2023;5(1):23\u201324.","DOI":"10.46234\/ccdcw2022.234"},{"issue":"6","key":"654_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783\u201391.","journal-title":"Cancer Discov"},{"issue":"12","key":"654_CR4","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1172\/JCI141777","volume":"130","author":"GL Shah","year":"2020","unstructured":"Shah GL, DeWolf S, Lee YJ, Tamari R, Dahi PB, Lavery JA, et al. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation. J Clin Invest. 2020;130(12):6656\u201367.","journal-title":"J Clin Invest"},{"issue":"5","key":"654_CR5","doi-asserted-by":"publisher","first-page":"e2210880","DOI":"10.1001\/jamanetworkopen.2022.10880","volume":"5","author":"E Khoury","year":"2022","unstructured":"Khoury E, Nevitt S, Madsen WR, Turtle L, Davies G, Palmieri C. Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: A systematic review and Meta-analysis. JAMA Netw Open. 2022;5(5):e2210880.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"654_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/2159-8290.CD-21-1441","volume":"12","author":"JE Fahrner","year":"2022","unstructured":"Fahrner JE, Lahmar I, Goubet AG, Haddad Y, Carrier A, Mazzenga M, et al. The Polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in patients with cancer and healthy individuals. Cancer Discov. 2022;12(4):958\u201383.","journal-title":"Cancer Discov"},{"issue":"22","key":"654_CR7","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.3390\/cancers14225630","volume":"14","author":"M Almasri","year":"2022","unstructured":"Almasri M, Bshesh K, Khan W, Mushannen M, Salameh MA, Shafiq A, et al. Cancer patients and the COVID-19 vaccines: considerations and challenges. Cancers (Basel). 2022;14(22):5630.","journal-title":"Cancers (Basel)"},{"key":"654_CR8","doi-asserted-by":"publisher","first-page":"108399","DOI":"10.1016\/j.pharmthera.2023.108399","volume":"245","author":"SV Retnakumar","year":"2023","unstructured":"Retnakumar SV, Chauvin C, Bayry J. The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases. Pharmacol Ther. 2023;245:108399.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"654_CR9","doi-asserted-by":"publisher","first-page":"e004157","DOI":"10.1136\/jitc-2021-004157","volume":"10","author":"Q Mei","year":"2022","unstructured":"Mei Q, Hu G, Yang Y, Liu B, Yin J, Li M, et al. Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study. J Immunother Cancer. 2022;10(3):e004157.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"654_CR10","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1158\/1078-0432.CCR-18-2360","volume":"25","author":"G Qiao","year":"2019","unstructured":"Qiao G, Wang X, Zhou L, Zhou X, Song Y, Wang S, et al. Autologous dendritic cell-Cytokine induced killer cell immunotherapy combined with S-1 plus cisplatin in patients with advanced gastric cancer: A prospective study. Clin Cancer Res. 2019;25(5):1494\u2013504.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"654_CR11","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1158\/1078-0432.CCR-17-0492","volume":"23","author":"N Jiang","year":"2017","unstructured":"Jiang N, Qiao G, Wang X, Morse MA, Gwin WR, Zhou L, et al. Dendritic cell\/Cytokine-Induced killer cell immunotherapy combined with S-1 in patients with advanced pancreatic cancer: A prospective study. Clin Cancer Res. 2017;23(17):5066\u201373.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"654_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s12094-018-1968-3","volume":"21","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Qiao G, Wang X, Song Y, Zhou X, Jiang N, et al. Combination of DC\/CIK-T celladoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients\u2019 preference-based study (PPPS). Clin Transl Oncol. 2019;21(6):721\u20138.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"654_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12094-015-1339-2","volume":"18","author":"X Wang","year":"2016","unstructured":"Wang X, Ren J, Zhang J, Yan Y, Jiang N, Yu J, et al. Prospective study of cyclophosphamide, Thiotepa, carboplatin combined with adoptive DC-CIK-T cellfollowed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged\u2009<\u200945). Clin Transl Oncol. 2016;18(1):82\u20137.","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"654_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s12094-013-1001-9","volume":"15","author":"J Ren","year":"2013","unstructured":"Ren J, Di L, Song G, Yu J, Jia J, Zhu Y, et al. Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences. Clin Transl Oncol. 2013;15(10):780\u20138.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"654_CR15","first-page":"3940","volume":"12","author":"Z He","year":"2020","unstructured":"He Z, Wang S, Qiao G, Wang X, Zhou X, Zhu S, et al. Clinical efficacy of intra-cavitary infusions of autologous dendritic cell\/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and Ascites. Am J Transl Res. 2020;12(7):3940\u201352.","journal-title":"Am J Transl Res"},{"issue":"sup1","key":"654_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/02656736.2019.1647350","volume":"36","author":"G Qiao","year":"2019","unstructured":"Qiao G, Wang X, Zhou X, Morse MA, Wu J, Wang S, et al. Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors. Int J Hyperth. 2019;36(sup1):74\u201382.","journal-title":"Int J Hyperth"},{"issue":"1","key":"654_CR17","doi-asserted-by":"publisher","first-page":"2431130","DOI":"10.1080\/02656736.2024.2431130","volume":"41","author":"J Ren","year":"2024","unstructured":"Ren J, Li C, Xu D, Wan K, Zeng C, Hu L, et al. Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinoma. Int J Hyperth. 2024;41(1):2431130.","journal-title":"Int J Hyperth"},{"key":"654_CR18","first-page":"1709","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Qiao G, Jiang N, et al. Serial assessment of Circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy. Am J Cancer Res. 2021;11:1709\u201318.","journal-title":"Am J Cancer Res"},{"key":"654_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","volume":"104","author":"S Paolucci","year":"2021","unstructured":"Paolucci S, Cassaniti I, Novazzi F, et al. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021;104:315\u20139.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"654_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/pathogens13060514","volume":"13","author":"S Gupta","year":"2024","unstructured":"Gupta S, Su H, Agrawal S, Demirdag Y, Tran M, Gollapudi S. Adaptive cellular responses following SARS-CoV-2 vaccination in primary antibody deficiency patients. Pathogens. 2024;13(6):514.","journal-title":"Pathogens"},{"issue":"11","key":"654_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","volume":"21","author":"M Reina-Campos","year":"2021","unstructured":"Reina-Campos M, Scharping NE, Goldrath AW. CD8\u2009+\u2009T cell metabolism in infection and cancer. Nat Rev Immunol. 2021;21(11):718\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"654_CR22","doi-asserted-by":"publisher","first-page":"e220130","DOI":"10.1001\/jamanetworkopen.2022.0130","volume":"5","author":"C V\u00e1rnai","year":"2022","unstructured":"V\u00e1rnai C, Palles C, Arnold R, Curley HM, Purshouse K, Cheng VWT, et al. Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19. JAMA Netw Open. 2022;5(2):e220130.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"654_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imm.13262","volume":"162","author":"SM Toor","year":"2021","unstructured":"Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology. 2021;162(1):30\u201343.","journal-title":"Immunology"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00654-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00654-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00654-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:24:48Z","timestamp":1744219488000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-025-00654-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00654-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5468024\/v1","asserted-by":"object"}]},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Fudan University Pudong Medical Center, Shanghai, China. Ethics number: 2021-IIT-021-E02.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to participate in this study was obtained from all patients at the time of admission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}